Monday, June 22, 2026

Tech Giants Escalate Race to Build Security-Focused AI Models as Cyber Defense Becomes Core Battleground

Global big tech companies are focused on developing AI models specialized in security.

South Korea’s Auto Exports Hit Record $72 Billion as Europe and Asia Offset U.S. Tariff Hit

South Korea's auto exports reached a record $71.99 billion in 2025, driven by eco-friendly vehicles and used car sales amid U.S. tariff challenges.

SK Innovation Invests 560 Billion KRW in AI Solutions: What This Means for SK Hynix

SK Innovation plans to invest $378 million in AI Company, an AI solutions firm by SK Hynix, over the next four years.

Tag: EMA

Sam Chun Dang Pharm Wins EMA Approval for Phase 1 Trial of Oral Insulin Candidate SCD0503

Samchundang Pharmaceutical's oral insulin candidate 'SCD0503' received final approval for Phase 1 clinical trials from EMA.

A 90-Minute Cancer Infusion Could Soon Be Cut to 5 Minutes—and Celltrion Wants to Lead It

Celltrion has applied for EMA approval of Herzuma SC, a new breast cancer treatment, enhancing drug delivery and patient convenience.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us